搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Cure Today
17 小时
The Importance of Gratitude During Cancer, Not Only in November
Gratitude was not something I learned in childhood. Well, I learned when to say, “Please” and “Thank you,” but I didn’t ...
Cure Today
14 小时
Parenting and Cancer: How Much Do Kids Need to Know?
Musician Danielia Cotton and her partner, attorney Sam Roberts, discuss how much they’ve shared with their daughter about ...
Cure Today
21 小时
Focusing Research on T-Cell ALL to Further Treatment Options
An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.
Cure Today
15 小时
Itovebi Combo May Improve Survival in Metastatic Breast Cancer Subtype
An Itovebi regimen demonstrated significantly longer progression-free survival compared with placebo in some with metastatic ...
Cure Today
1 天
FDA Accepts New Drug Application for Nubeqa Combo for Prostate Cancer Subset
The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic ...
Cure Today
1 天
A Survivor's Thanksgiving: Celebrating Life's Blessings Post-Cancer
Celebrating Thanksgivings after cancer has made me appreciate all aspects of life even more and to truly cherish times of ...
Cure Today
1 天
Opdivo May Improve Outcomes in High-Risk Muscle-Invasive Bladder Cancer
Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk ...
Cure Today
1 天
Understanding Treatment Sequences in Managing R/R CLL
For patients with relapsed or refractory CLL, an expert explained that it’s important to understand the order of how ...
Cure Today
1 天
Opdivo Combo Shows Better Survival Benefits in Advanced Hodgkin Lymphoma
Patients with advanced Hodgkin lymphoma demonstrated significantly improved survival benefits with an Opdivo regimen versus ...
Cure Today
5 天
FDA Approves Ziihera for Some With Biliary Tract Cancer
The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...
Cure Today
6 天
PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels ...
Cure Today
6 天
What Patients with Breast Cancer Need to Know About Lymphedema Risk
CURE® spoke with a physical therapist specializing in oncology to find out more about this condition some patients with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈